Celltrion
068270.KS
#648
Rank
C$42.19 B
Marketcap
$203.72
Share price
2.97%
Change (1 day)
37.47%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$3.07 B

According to Celltrion 's latest financial reports the company's total liabilities are C$3.07 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$1.74 B0.79%
2021-12-31C$1.72 B-7.61%
2020-12-31C$1.86 B68.98%
2019-12-31C$1.10 B-0.29%
2018-12-31C$1.10 B6.47%
2017-12-31C$1.04 B13.58%
2016-12-31C$0.91 B-17.24%
2015-12-31C$1.10 B7.42%
2014-12-31C$1.03 B14.74%
2013-12-31C$0.89 B37.22%
2012-12-31C$0.65 B47.14%
2011-12-31C$0.44 B33.56%
2010-12-31C$0.33 B33.24%
2009-12-31C$0.25 B-8.96%
2008-12-31C$0.27 B645.06%
2007-12-31C$36.9 M